<DOC>
	<DOC>NCT02073019</DOC>
	<brief_summary>The purpose of this study is to determine whether BL-8040 is safe, tolerable and effective in the mobilization of Hematopoietic Stem Cells (HSC) in healthy volunteers</brief_summary>
	<brief_title>A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male subjects BMI between 18 and 30 kg/m2 and Weight â‰¥ 60 Kg Subjects must be either surgically sterilized (vasectomy), or if their partner is of childbearing potential, must use two methods of contraception, one of which must be a barrier method, from the first dose until 3 months after the last dose Subject is able and willing to comply with the requirements of the protocol History of clinically significant disease Any illness within the 4 weeks prior to the screening examination Any history of alcohol and/or drug of abuse addiction and/or active / past (up to 2 years before screening) nicotine consumption Clinically relevant deviation from normal in the physical examination and vital signs at screening or baseline Clinically relevant laboratory abnormalities identified at screening or baseline Positive tests at screening for HIV I &amp; II, hepatitis B and/or hepatitis C in both parts or positive tests for Syphilis, HTLV I &amp; II and Nucleic Acid Test (NAT) for HIV and HBV Positive test for urine drugs of abuse or by anamnesis (Barbiturates, Benzodiazepines, Amphetamines, Opiates, Cocaine, Cannabinoids, Methadone, Phencyclidine, and Tricyclic Antidepressants) and/or positive alcohol blood test Subjects who have lost or donated in excess of 400 mL of blood within 3 months prior to Day 1 of the study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>